Table 1 Preoperative patients details
From: St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry
Variablesa | All implants (n = 178) |
|---|---|
Demographics | Â |
 Age, yrs | 75.4 ± 7.7 (72-81) |
 Female, n (%) | 83 (46.6) |
 BSA, m2 | 1.60 ± 0.33 (1.38-1.79) |
Cardiac presentation | Â |
 Previous AMI, n (%) | 22 (12.4) |
 CAD, n (%) | 68 (38.2) |
 History of AF, n (%) | 25 (14.0) |
 Preoperative NYHA, n (%) |  |
  Class I | 13 (7.3) |
  Class II | 72 (40.4) |
  Class III | 78 (43.8) |
  Class IV | 15 (8.4) |
Comorbidities | Â |
 Hypertension, n (%) | 136 (76.4) |
 Diabetes, n (%) | 49 (27.5) |
 COPD, n (%) | 24 (13.5) |
 PVD, n (%) | 52 (29.2) |
 Dyslipidemia, n (%) | 83 (46.6) |
 Renal dysfunction, n (%) | 13 (7.3) |
 Renal failure-dialysis, n (%) | 7 (3.9) |
 Logistic EuroSCORE, % | 7.7 ± 6.7 (3.0-11.0) |
Etiology | Â |
 Calcified, n (%) | 120 (67.4) |
 Rheumatic, n (%) | 11 (6.2) |
 Degenerative, n (%) | 35 (19.7) |
 Annular dilatation, n (%) | 5 (2.8) |
 Endocarditis, n (%) | 7 (3.9) |